Skip to Main Content

Author Details

Lingyun Cheng
Shiley Eye Institute, University of California San Diego
1998
161
34
PMIDPaper TitleJournal TitlePublished Year
37988102ARTIFICIAL INTELLIGENCE FOR OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY-BASED DISEASE ACTIVITY PREDICTION IN AGE-RELATED MACULAR DEGENERATION.Retina2024
36727800DIRECT MACULAR HOLE MANIPULATION RESULTS IN HIGH SUCCESS RATE IN SECONDARY MACULAR HOLE REPAIR.Retina2023
36991025Retinal tissue and microvasculature loss in COVID-19 infection.Sci Rep2023
34806258Definition of large niche after Cesarean section based on prediction of postmenstrual spotting: Chinese cohort study in non-pregnant women.Ultrasound Obstet Gynecol2022
35652073Biomechanical Considerations of Patching Material for Posterior Scleral Reinforcement Surgery.Front Med (Lausanne)2022
36748946Effective treatment of retinal neovascular leakage with fusogenic porous silicon nanoparticles delivering VEGF-siRNA.Nanomedicine (Lond)2022
33141787REPLACEMENT OF LIDOCAINE GEL WITH TOPICAL PROPARACAINE ANESTHESIA FOR ROUTINE INTRAVITREAL INJECTIONS: A Comparative Study.Retina2021
33771623Controlled release of triamcinolone from an episcleral micro film delivery system for open-globe eye injuries and proliferative vitreoretinopathy.J Control Release2021
34903819Changes of plasma nitric oxide, endothelin-1, and blood coagulation following intravitreal conbercept.Sci Rep2021
34543243CHOROIDAL IMAGING BIOMARKERS TO PREDICT HIGHLY RESPONSIVE AND RESISTANT CASES TREATED WITH STANDARDIZED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR REGIMEN IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Retina2021
31531945Implication of inflammatory cytokines in the aqueous humour for management of macular diseases.Acta Ophthalmol2020
33100053A sustained dual drug delivery system for proliferative vitreoretinopathy.Drug Deliv2020
32818352Single subconjunctival injection formulation using sol-gel mesoporous silica as a controlled release system for drop-free post-cataract surgery care.J Cataract Refract Surg2020
32393079Intravitreal safety profiles of sol-gel mesoporous silica microparticles and the degradation product (Si(OH)<sub>4</sub>).Drug Deliv2020
31302628Factors associated with extended remission in neovascular age-related macular degeneration on pro re nata treatment protocol.Br J Ophthalmol2020
30529169Hydrophobic drug adsorption loss to syringe filters from a perspective of drug delivery.J Pharmacol Toxicol Methods2019
30028411AGE-RELATED MACULAR DEGENERATION-ASSOCIATED PERIPAPILLARY CHOROIDAL NEOVASCULARIZATION IN THE ERA OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.Retina2019
30015764ANATOMICAL AND FUNCTIONAL TESTING IN DIABETIC PATIENTS WITHOUT RETINOPATHY: Results of Optical Coherence Tomography Angiography and Visual Acuity Under Varying Contrast and Luminance Conditions.Retina2019
31602345Acute Rabbit Eye Model for Testing Subretinal Prostheses.Transl Vis Sci Technol2019
30837544Inflammatory cytokines in highly myopic eyes.Sci Rep2019
30806775Durability of every-8-week aflibercept maintenance therapy in treatment-experienced neovascular age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol2019
30900817Sub-Tenon depository triamcinolone and glycaemic management in diabetic patients.Acta Ophthalmol2019
29461171New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies.Drug Deliv2018
30025077Genipin-Crosslinked Donor Sclera for Posterior Scleral Contraction/Reinforcement to Fight Progressive Myopia.Invest Ophthalmol Vis Sci2018
29996687Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy.Drug Deliv2018
30550611In Vivo Photovoltaic Performance of a Silicon Nanowire Photodiode-Based Retinal Prosthesis.Invest Ophthalmol Vis Sci2018
29115885A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation.Drug Deliv2017
29223226Clinical implication of triamcinolone in aqueous humor after depository sub-Tenon application.J Cataract Refract Surg2017
25708574Perioperative pharmacological management of choroidal detachment associated with rhegmatogenous retinal detachment.Acta Ophthalmol2016
27717742Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.J Control Release2016
27071973Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL).Acta Biomater2016
26882530Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.Invest Ophthalmol Vis Sci2016
25077534Impact on intraocular pressure after 20-mg decanted triamcinolone acetonide (kenalog) injection when using prophylactic antiglaucoma therapy.Retina2015
26431297SLO-Microperimetry in Wet Age-Related Macular Degeneration During Anti-VEGF Therapy.Ophthalmic Surg Lasers Imaging Retina2015
26047049Real-Time Monitoring of Suprachoroidal Space (SCS) Following SCS Injection Using Ultra-High Resolution Optical Coherence Tomography in Guinea Pig Eyes.Invest Ophthalmol Vis Sci2015
26087110A sustained intravitreal drug delivery system with remote real time monitoring capability.Acta Biomater2015
25829415A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics.Invest Ophthalmol Vis Sci2015
25700623Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.J Control Release2015
25777818Significance of the hyperautofluorescent ring associated with choroidal neovascularisation in eyes undergoing anti-VEGF therapy for wet age-related macular degeneration.Br J Ophthalmol2015
25439434Transscleral permeation of subtenon triamcinolone in different vitreoretinal diseases.Ophthalmology2015
25513956Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system.Eur J Pharm Biopharm2015
25613937Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.Invest Ophthalmol Vis Sci2015
24217703Macular choroidal volume variations in highly myopic eyes with myopic traction maculopathy and choroidal neovascularization.Retina2014
25446320Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.Exp Eye Res2014
25312463[Characteristic of ocular safety profile of triamcinolone made in China].Zhonghua Yan Ke Za Zhi2014
24793657Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin.Acta Biomater2014
24509544Posterior scleral reinforcement on progressive high myopic young patients.Optom Vis Sci2014
24695064Fluorescein angiography versus optical coherence tomography-guided planning for macular laser photocoagulation in diabetic macular edema.Retina2014
24424270Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.J Control Release2014
24076072Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-ε-caprolactone matrix.Acta Biomater2014
  • 1 - 50 of 161

Recommended Authors

the Scripps Research Institute
Career Start Year 2013
Number of shared co-authors 1
Kresge Eye Institute/Wayne State University Department of Ophthalmology
Career Start Year 2012
Number of shared co-authors 0
Universidade Federal de Sao Paulo
Career Start Year 2006
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 2005
Number of shared co-authors 1
Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic
Career Start Year 2005
Number of shared co-authors 0
New York University School of Medicine, New York University Langone Health
Career Start Year 2004
Number of shared co-authors 2
University of California san francisco
Career Start Year 2002
Number of shared co-authors 3
Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida
Career Start Year 2000
Number of shared co-authors 4
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year 1999
Number of shared co-authors 1
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 0
University Hospital Wurzburg
Career Start Year 1998
Number of shared co-authors 0
Yokohama City University Medical Center
Career Start Year 1998
Number of shared co-authors 0
University of California davis
Career Start Year 1998
Number of shared co-authors 2
New York Eye and Ear Infirmary of Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 2
Medical College of Wisconsin
Career Start Year 1994
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1993
Number of shared co-authors 0
Wills Eye Hospital/Mid Atlantic Retina
Career Start Year 1992
Number of shared co-authors 2
Byers Eye Institute, Stanford University
Career Start Year 1990
Number of shared co-authors 1
Harvard Medical School
Career Start Year 1989
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 3
University of Michigan Kellogg Eye Center ann arbor
Career Start Year 1987
Number of shared co-authors 0
MicroInvasive Ocular Surgery Clinic
Career Start Year 1987
Number of shared co-authors 1
The University of Sydney Save Sight Institute
Career Start Year 1987
Number of shared co-authors 1
University of Illinois at Chicago
Career Start Year 1986
Number of shared co-authors 2
University of Alabama Callahan Eye Hospital and Clinics
Career Start Year 1986
Number of shared co-authors 0
From the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year 1986
Number of shared co-authors 2
University of South Carolina School of Medicine
Career Start Year 1985
Number of shared co-authors 3
University of Wisconsin, Wisconsin EyeKor Inc.
Career Start Year 1981
Number of shared co-authors 1
Tufts Medical Center
Career Start Year 1975
Number of shared co-authors 1

Collaborators

University of California San Diego
Co-authored papers 134
Shiley Eye Institute, University of California San Diego
Co-authored papers 45
Moorfields Eye Hospital Dubai.
Co-authored papers 43
University of Pittsburgh
Co-authored papers 20
Shiley Eye Institute, University of California
Co-authored papers 11
Shiley Eye Institute, University of California San Diego
Co-authored papers 3
Institute for Global Food Security, Queen's University Belfast
Co-authored papers 2
University Eye Hospital, Ludwig-Maximillians-University
Co-authored papers 2
Oakland University William Beaumont School of Medicine
Co-authored papers 2
Shiley Eye Institute, University of California San Diego
Co-authored papers 2
University of California San Diego
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Center for Computational Biology & Bioinformatics (CCBB), University of California
Co-authored papers 1
Co-authored papers 1
Goldschleger Eye Institute, Sheba Medical Center
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Shiley Eye Institute, University of California San Diego
Co-authored papers 1
Co-authored papers 1
Shiley Eye Institute, Rady Children's Hospital, University of California
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Pittsburgh
Co-authored papers 1
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Shiley Eye Institute, University of California San Diego
Co-authored papers 1
The Retina Service of Wills Eye Hospital
Co-authored papers 1
Shiley Eye Institute, University of California
Co-authored papers 1